Beranda › Sklerosis Lateral Amiotrofik › California
Uji klinis Sklerosis Lateral Amiotrofik di California
23 studi untuk Sklerosis Lateral Amiotrofik mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- USA004, La Jolla
- USA002, Palo Alto
Menerima pesertaFase 1
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07290062Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- California Pacific Medical Center, San Francisco
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07322003RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- University of California San Diego Medical Center, San Diego
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07287397Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Zydus US015, La Jolla
- Zydus US008, Orange
- Zydus US013, San Francisco
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07023835ASSESS ALL ALS Study
- University of California, Irvine, Irvine
- University of California San Diego, La Jolla
- University of California, Los Angeles, Los Angeles
- dan 1 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT06578195PREVENT ALL ALS Study
- University of California San Diego, La Jolla
- University of California Irvine, Orange
- University of California, San Francisco, San Francisco
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT06581861Study of COYA 302 for the Treatment of ALS
- Cedars-Sinai Medical Center, Los Angeles
- California Pacific Medical Center, San Francisco
Menerima pesertaFase 2/3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07161999ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- University of California, Los Angeles, Los Angeles
- University of California, San Diego, San Diego
- University of California San Francisco, San Francisco
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04363684PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
- University of California San Diego, La Jolla
- Sutter Health - California Pacific Medical Center Research Institute, San Francisco
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT07142291Clinical Procedures to Support Research in ALS
- University of California, Irvine, Irvine
- Stanford University, Palo Alto
- California Pacific Medical Center, San Francisco
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT03489278A Study of Ranolazine in ALS
- University of California, San Francisco, San Francisco
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT06527222Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
- Loma Linda University, Loma Linda
Menerima pesertaStudi observasional
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT04097158Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
- Stanford University School of Medicine, Stanford
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT05724173BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- University of California, Davis, Sacramento
- Stanford University School of Medicine, Stanford
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT00912041ALS/MND Natural History Study Data Repository
- Loma Linda University Health, Loma Linda
- Kaiser Permanente, Los Angeles
Menerima pesertaStudi observasional
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT05966038Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
- University of California, Davis, Sacramento
Menerima peserta
Usia 22 hingga 75 · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT07357428AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
- University of California, San Diego, La Jolla
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT06665165Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
- University of California, Davis, Sacramento
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 1 Des 2025 · NCT06094205Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- University of California San Diego, San Diego
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT05137665Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- University of Southern California, Los Angeles
Menerima pesertaFase 3
Usia 18 hingga 81 · Semua jenis kelamin · Diperbarui 12 Sep 2025 · NCT03127267Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- UCSF, San Francisco
- Stanford University, Stanford
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 2 Mei 2025 · NCT05395624Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
- Cognixion, Santa Barbara
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2025 · NCT06810219Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.